Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
Statement |
---|
Ray, as you know, I've always been an extremely supportive and appreciative of management shareholder for many, many, many years |
American Shared had another solid quarter, with year-over-year revenue increasing by 6.3% to $5.1 million for the third quarter |
AMS consistently generates positive cash flow even throughout the pandemic |
There's been costs associated with just regulatory filings that are necessary to obtain the business and other consultants and advisers that we feel has been very beneficial to enhance our ability to close the opportunities |
In closing, we've built good momentum both internationally and in the U.S., and AMS has a full pipeline of opportunities and is supported by a strong financial position |
As far as our stock price, I think as I've often mentioned, I really believe our stock is undervalued |
We're excited about that future |
So all I can say is keep in touch, our stock is undervalued |
We're especially excited by three unique opportunities, which we first mentioned on our last call |
I'm proud to say that AMS will have the most advanced radiation cancer treatment system in their region when the installations are complete |
Our in-house customer advocate has been a great addition |
And our business order intake, our pipeline has been growing and our order intake is slowly increasing our rate of orders that we're taking in is increasing |
He has also continued to help improve the activity levels on our Gamma Knife sites |
We continue to maintain a tight rein on direct costs and the gross margin grew 7.4% to $2.1 million |
The booth was fully staffed with our team, and it was a great opportunity for us to meet with customers, partners and OEMs |
Internationally, the installation of new equipment with expanded treatment offerings at two of our locations has progressed well |
We attribute this growth to our sales team, which has hit its stride and our expanded financial solutions and closer integration with our strategic OEMs on targeted prospects |
We're a profitable company |
In the third quarter, Gamma Knife procedures increased approximately 8% period-over-period after improving the utilization in the second quarter as well |
During the third quarter, the sales pipeline continued to grow |
We're growing, and we're going to grow more incrementally |
I really believe American shares never been in a stronger position with the pipeline opportunities we have, our financial position, capital we have ready to be deployed |
In closing, I hope I've conveyed some of the excitement that we all feel here at AMS |
Domestic revenue was $4.1 million, an increase of 1.1% and international revenue was $1 million compared to $727,000 a year ago, an increase of 35.9% |
Third quarter revenue increased 6.3% to $5.1 million compared to $4.8 million in the year ago period |
I think our performance has been steady |
Total Gamma Knife revenue increased 9.9% to $2.7 million |
Be well, and have a great evening |
We also attended three conferences in Ecuador this year, where we've developed great referral sources |
In the third quarter, we invested approximately $320,000, advancing these unique opportunities |
Statement |
---|
And I think our recent stock price decline, I think the market misunderstood some of our recent, in particular, second quarter, let's say, we reported a loss, and we had a couple of blips in our second quarter |
Third quarter revenue for the proton therapy system in Florida was $2.2 million, a decrease of 5.9% primarily due to a decrease in fractions, offset by continued increases in average reimbursement |
The stock is down 15% since just the last conference call |
To me, that would signal that your growth opportunities were not as robust as maybe |
Total proton therapy fractions in the third quarter were 1,188, a decrease of 12.8% or 175 fractions |
The decrease was primarily due to higher interest expense and higher selling and administrative expense in support of the company's new business opportunities |
This quarter, we reported a profit |
Actual results may vary materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the company's filings with the SEC |
There's been legal costs |
The decrease was primarily due to lower earnings, return to provision adjustments arising from foreign tax returns and permanent domestic tax differences |
Please consider a small donation if you think this website provides you with relevant information